skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Androgen therapy and atherosclerotic cardiovascular disease

Review

(2901) Views  (681) Full article downloads

Authors: K-CY McGrath, LS McRobb, AK Heather

Published Date March 2008 Volume 2008:4(1) Pages 11 - 21
DOI: http://dx.doi.org/10.2147/VHRM.S1255

K-CY McGrath1, LS McRobb1,2, AK Heather1,2

1Heart Research Institute, Camperdown, NSW, Australia; 2Discipline of Medicine, University of Sydney, Sydney, NSW, Australia

Abstract: Cardiovascular disease (CVD) remains the leading cause of death in Western society today. There is a striking gender difference in CVD with men predisposed to earlier onset and more severe disease. Following the recent reevaluation and ongoing debate regarding the estrogen protection hypothesis, and given that androgen use and abuse is increasing in our society, the alternate view that androgens may promote CVD in men is assuming increasing importance. Whether androgens adversely affect CVD in either men or women remains a contentious issue within both the cardiovascular and endocrinological fraternities. This review draws from basic science, animal and clinical studies to outline our current understanding regarding androgen effects on atherosclerosis, the major CVD, and asks where future directions of atherosclerosis-related androgen research may lie.








Readers of this article also read:
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University